BE902586A - Composes a activite antibacterienne, leur procede de fabrication et compositions pharmaceutiques les comprenant. - Google Patents

Composes a activite antibacterienne, leur procede de fabrication et compositions pharmaceutiques les comprenant.

Info

Publication number
BE902586A
BE902586A BE0/215132A BE215132A BE902586A BE 902586 A BE902586 A BE 902586A BE 0/215132 A BE0/215132 A BE 0/215132A BE 215132 A BE215132 A BE 215132A BE 902586 A BE902586 A BE 902586A
Authority
BE
Belgium
Prior art keywords
compounds
group
manufacturing
same
pharmaceutical compositions
Prior art date
Application number
BE0/215132A
Other languages
English (en)
French (fr)
Inventor
F Villani
A Renzetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of BE902586A publication Critical patent/BE902586A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
BE0/215132A 1984-06-04 1985-06-04 Composes a activite antibacterienne, leur procede de fabrication et compositions pharmaceutiques les comprenant. BE902586A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8421241A IT1213173B (it) 1984-06-04 1984-06-04 Composti ad attivita'antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche.

Publications (1)

Publication Number Publication Date
BE902586A true BE902586A (fr) 1985-09-30

Family

ID=11178899

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215132A BE902586A (fr) 1984-06-04 1985-06-04 Composes a activite antibacterienne, leur procede de fabrication et compositions pharmaceutiques les comprenant.

Country Status (7)

Country Link
KR (1) KR870000286B1 (pt)
BE (1) BE902586A (pt)
CH (1) CH666264A5 (pt)
ES (1) ES8604193A1 (pt)
GB (1) GB2160519B (pt)
IT (1) IT1213173B (pt)
PT (1) PT80590B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
US5286754A (en) * 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
FR2594439B1 (fr) * 1986-02-19 1989-04-21 Vetoquinol Sa Nouveaux derives ester, thioester et amide de quinolone, leur procede de preparation et leur application en therapeutique
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
US5066800A (en) * 1990-04-27 1991-11-19 Hoffmann-La Roche Inc. Qunoline intermediates useful therein for synthesizing antibacterial compounds
ES2050594B1 (es) * 1991-12-31 1994-12-16 Ind Quimica Agropecuaria S A Procedimiento para la obtencion de acidos 6-fluoro-1,4-dihidro-4-oxo-7-piperazino-quinolin-3-carboxilicos sustituidos en 1-n.
ES2048110B1 (es) * 1992-07-22 1995-02-01 Prodesfarma Sa Procedimiento de preparacion de 2,2-dioxidos de pirazino (2,3-c)-1,2,6-tiadiazina n(1) sustituidos.
EP1609818B1 (de) * 2004-06-24 2010-03-10 Bayer MaterialScience AG Thermostabilisierte Polycarbonat-Zusammensetzungen
CN109942488A (zh) * 2019-04-04 2019-06-28 山东省联合农药工业有限公司 一种喹啉羧酸酯类化合物及其制备方法与用途

Also Published As

Publication number Publication date
KR860000282A (ko) 1986-01-27
PT80590A (en) 1985-07-01
ES8604193A1 (es) 1986-01-16
ES543820A0 (es) 1986-01-16
IT1213173B (it) 1989-12-14
GB2160519A (en) 1985-12-24
PT80590B (en) 1987-04-21
GB8513962D0 (en) 1985-07-03
KR870000286B1 (ko) 1987-02-25
IT8421241A0 (it) 1984-06-04
CH666264A5 (it) 1988-07-15
GB2160519B (en) 1988-07-20

Similar Documents

Publication Publication Date Title
FR2372176A1 (fr) Procede de preparation de derives d'alcoxy-3 androstanones-17
HUT51267A (en) Process for prodicing new thiochroman esters of phenols and terephthalates and pharmaceutical compositions comprising same as active ingredient
BE900345A (fr) Composition pharmaceutique ophtalmiques a base d'un derive d'acide phenylacetique.
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
KR930703303A (ko) 1, 4-벤조티아제핀 유도체
BE902586A (fr) Composes a activite antibacterienne, leur procede de fabrication et compositions pharmaceutiques les comprenant.
DK76086A (da) Alken, alkyn eller cykloalkylenderivater
KR890009845A (ko) 아릴옥시페닐 프로필아민, 이의 제조방법 및 용도
BE901987A (fr) Derives d'alcanolamines et inhibiteurs de l'agregation des plaquettes en contenant comme principe actif.
BE904983A (fr) Acides propenylaminothiazolylcephalosporaniques 3-substitues et leurs esters.
KR890701576A (ko) 2,5,6,7-테트라놀-4,8-인터-m-페닐렌 PGI₂유도체 및 그 제조법과 용도
BE905654A (fr) Derives de la armstrong 2-1,2,4-triazoline-5-one, procede pour leur preparation et leurs utilisations.
KR880011163A (ko) 4- 벤질- 피페라지닐 하이드라존
EP0966455B1 (de) Oxirancarbonsäuren für die behandlung von diabetes
BE1002696A3 (fr) Derives de dioxazocine, leur procede de preparation et compositions pharmaceutiques les contenant.
BE1003280A3 (fr) Derives oxo-isoindoliniques optiquement actifs.
BE901831A (fr) Derives d'aminodiaryl sulfoxyde, procede pour leur preparation et compositions pharmaceutiques et pesticides les contenant.
BE899823A (fr) Acide 2-(4-biphenylyl)-4-hexenoique et ses derives, doues d'une activite antiinflammatoire.
FR2394527A1 (fr) N-(3'-phenylthiopropyl)-3,3-diphenylpropylamines substituees dotees d'activite pharmacologique et compositions pharmaceutiques les contenant
ES510828A0 (es) "un procedimiento para la preparacion de un derivado de morfolina".
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient
BE1002110A4 (fr) Derives de l'isoquinoleine.
FR2444666A1 (fr) Derives du cyclododecane, leur procede de preparation et medicaments les contenant
KR870001153A (ko) 디페녹시에틸아민 유도체가 함유된 약제조성물 및 그의 생산방법
FR2407206A1 (fr) Nouveaux derives de benzimidazole, compositions pour l'agriculture les contenant et procede pour leur preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CHIESI FARMACEUTICI S.P.A.

Effective date: 19890630